Risk of Periprosthetic Joint Infection after Intra-Articular Injection: Any Difference among Shoulder, Knee and Hip?

Area of Science:

• Orthopedics
• Rheumatology
• Infectious Disease

Background:

• Osteoarthritis (OA) is a degenerative joint disease impacting cartilage.
• Prosthetic joint replacement is the definitive OA treatment, with rising demand.
• Conservative pain management, including intra-articular injections, aims to delay surgery.

Purpose of the Study:

• To determine the correlation between intra-articular injection characteristics and subsequent joint infection risk.
• To assess if injection type, dosage, or timing influences the risk of periprosthetic joint infection (PJI).
• To inform clinical practice regarding the safe use of injections prior to OA surgery.

Main Methods:

• Literature review of case studies involving intra-articular injections and subsequent joint infections.
• Analysis of injection parameters: type of substance, number of doses, and time interval to surgery.
• Correlation analysis to identify potential links between injection variables and infection outcomes.

Main Results:

• Preliminary findings suggest a potential link between specific injection parameters and increased infection risk.
• Further analysis is required to establish definitive correlations and causative relationships.
• Identifying at-risk injection protocols is critical for patient safety.

Conclusions:

• Intra-articular injections, while useful for pain management, carry a risk of joint infection, a major cause of revision surgery.
• Understanding the relationship between injection specifics and infection risk is vital for optimizing OA patient care.
• Clinical guidelines may need refinement to mitigate infection risks associated with pre-surgical injections.